ArticleAnti-cancer drugs2010

Targeting the efficacy of a dendrimer-based nanotherapeutic in heterogeneous xenograft tumors in vivo.

Andrzej Myc et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.